The ability to rationally manipulate and augment the cytoplasmic membrane can be used to overcome many of the challenges faced by conventional cellular therapies and provide innovative opportunities when combined with new biotechnologies. The focus of this review is on emerging strategies used in cell functionalization, highlighting both pioneering approaches and recent developments. These will be discussed within the context of future directions in this rapidly evolving field.
HuhDMatthewsBDMammotoAMontoya-ZavalaMHsinHYIngberDE. Reconstituting organ-level lung functions on a chip. Science2009; 328: 1662–8.
2.
DerbyB. Printing and prototyping of tissues and scaffolds. Science2012; 338: 921–7.
3.
GeorgeJC. Stem cell therapy in acute myocardial infarction: a review of clinical trials. Transl Res2010; 155: 10–19.
4.
StrauerBEKornowskiR. Stem cell therapy in perspective. Circulation2003; 107: 929–34.
5.
GreenbergPD. Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells. Adv Immunol1991; 49: 281–355.
6.
CimaLGVacantiJPVacantiCIngberDMooneyDLangerR. Tissue engineering by cell transplantation using degradable polymer substrates. J Biomech Eng1991; 113: 143–51.
7.
EdwardsRGBavisterBDSteptoePC. Early stages of fertilization in vitro of human oocytes matured in vitro. Nature1969; 221: 632–5.
8.
HsuHXiongJGoeddelDV. The TNF receptor 1 associated protein TRADD signals cell death and NF kappa B activation. Cell1995; 81: 495–504.
9.
DzionekAInagakiYOkawaKNagafuneJRockJSohmaYWinkelsGZyskMYamaguchiYSchmitzJ. Plasmacytoid dendritic cells: from specific surface markers to specific cellular functions. Hum Immunol2002; 63: 1133–48.
10.
BloemkolkJ-WGrayMRMerchantFMosmannTR. Effect of temperature on hybridoma cell cycle and MAb production. Biotechnol Bioeng1992; 40: 427–31.
11.
MaldaJKleinTJUptonZ. The roles of hypoxia in the in vitro engineering of tissues. Tissue Eng2007; 13: 2153–62.
ArmstrongJPKShakurRHorneJPDickinsonSCArmstrongCTLauKKadiwalaJLoweAMannSAndersonJLRPerrimanAWHollanderAP. Artificial membrane binding proteins stimulate oxygenation of stem cells during tissue engineering of large cartilage constructs. Nat Comm2015; 6: 1–6.
14.
KampfN. The use of polymers for coating of cells. Polym Advan Technol2003; 905: 896–905.
15.
JuilleratFKBorcardFStaedlerDScalettaCApplegateLAComasHGaucklerLJGerber-LemaireSJuillerat-JeanneretLGonzenbachUT. Functionalization of microstructured open-porous bioceramic scaffolds with human fetal bone cells. Bioconjugate Chem2012; 23: 2278–90.
LanctotPMGageFHVarkiAP. The glycans of stem cells. Curr Opin Chem Biol2007; 11: 373–80.
23.
KyteJ. Molecular considerations relevant to the mechanism of active transport. Nature1981; 292: 201–4.
24.
MagerMDLaPointeVStevensMM. Exploring and exploiting chemistry at the cell surface. Nat Chem2011; 3: 582–9.
25.
KholodenkoBN. Cell-signalling dynamics in time and space. Nat Rev Mol Cell Biol2006; 7: 165–76.
26.
SlettenEMBertozziCR. Bioorthogonal chemistry: fishing for selectivity in a sea of functionality. Angew Chem Int Ed2009; 48: 6974–98.
27.
NelAEMädlerLVelegolDXiaTHoekEMVSomasundaranPKlaessigFCastranovaV. Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater2009; 8: 543–57.
28.
BorcardFGodinatAStaedlerDBlancoHCDumontA-LChapuis-BernasconiCScalettaCApplegateLAJuilleratFKGonzenbachUTGerber-LemaireSJuillerat-JeanneretL. Covalent cell surface functionalization of human fetal osteoblasts for tissue engineering. Bioconjugate Chem2011; 22: 1422–32.
29.
KatoKItohCYasukouchiTNagamuneT. Rapid protein anchoring into the membranes of mammalian cells using oleyl chain and poly(ethylene glycol) derivatives. Biotechnol Prog2004; 20: 897–904.
30.
PalcheskoRNSzymanskiJMSahuAMFeinbergAW. Shrink wrapping cells in a defined extracellular matrix to modulate the chemo-mechanical microenvironment. Cell Mol Bioeng2014; 7: 355–68.
31.
XiaLMcDanielJMYagoTDoedenAMceverRP. Surface fucosylation of human cord blood cells augments binding to P-selectin and E-selectin and enhances engraftment in bone marrow. Blood2004; 104: 3091–6.
32.
SacksteinRMerzabanJSCainDWDagiaNMSpencerJALinCPWohlgemuthR. Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone. Nat Med2008; 14: 181–7.
33.
SinghNPYolcuESAskenasyNShirwanH. ProtEx: a novel technology to display exogenous proteins on the cell surface for immunomodulation. Ann N Y Acad Sci2005; 1056: 344–58.
34.
YolcuESAskenasyNSinghNPCherradiS-ELShirwanH. Cell membrane modification for rapid display of proteins as a novel means of immunomodulation: FasL-decorated cells prevent islet graft rejection. Immunity2002; 17: 795–808.
35.
AskenasyNYolcuEWangZShirwanH. Display of Fas ligand protein on cardiac vasculature as a novel means of regulating allograft rejection. Circulation2003; 107: 1525–31.
36.
SinghNPYolcuESTaylorDDSinghNPYolcuESTaylorDDGercel-TaylorCMetzingerDSDreisbachSKShirwanH. A novel approach to cancer immunotherapy: tumor cells decorated with CD80 generate effective antitumor immunity. Cancer Res2003; 63: 4067–73.
37.
SinghNPMillerRWYolcuESKilincMOOechsliMHusebyRTaylorDDPerryMTLaroccaRVShirwanH. Primary tumor cells resected from cancer patients and decorated with a novel form of CD80 protein serve as effective antigen-presenting cells for the induction of autologous T cell immune responses ex vivo. Hum Gene Ther2006; 17: 334–46.
38.
YinWHeQHuZChenZQifengMZhichunSZhihuiQXiaoxiaNLiJGaoJ. A novel therapeutic vaccine of GM-CSF/TNFalpha surface-modified RM-1 cells against the orthotopic prostatic cancer. Vaccine2010; 28: 4937–44.
WilsonMJHatfieldDL. Incorporation of modified amino acids into proteins in vivo. Biochim Biophys Acta1984; 781: 205–15.
42.
KayserHZeitlerRKannichtCGrunowDNuckRReutterW. Biosynthesis of a nonphysiological sialic acid in different rat organs, using N-propanoyl-D-hexosamines as precursors. J Biol Chem1992; 267: 16934–8.
43.
KepplerOTStehlingPHerrmannMKayserHGrunowDReutterWPawlitaM. Biosynthetic modulation of sialic acid-dependent virus-receptor interactions of two primate polyoma viruses. J Biol Chem1995; 270: 1308–14.
44.
SaxonEBertozziCR. Cell surface engineering by a modified staudinger reaction. Science2000; 287: 2007–11.
45.
DuJChePWangZAichUYaremaKJ. Designing a binding interface for control of cancer cell adhesion via 3D topography and metabolic oligosaccharide engineering. Biomaterials2011; 32: 5427–37.
46.
OkeleyNMTokiBEZhangXJeffreySCBurkePJAlleySCSenterPD. Metabolic engineering of monoclonal antibody carbohydrates for antibody – drug conjugation. Bioconjugate Chem2013; 24: 1650–5.
KhoYKimSCJiangCBarmaDKwonSWChengJJanisJWeinbaumCTamanoiFFalckJZhaoY. A tagging-via-substrate technology for detection and proteomics of farnesylated proteins. Proc Natl Acad Sci U S A2004; 101: 12479–84.
49.
KiickKLSaxonETirrellDABertozziCR. Incorporation of azides into recombinant proteins for chemoselective modification by the Staudinger ligation. Proc Natl Acad Sci U S A2001; 99: 19–24.
50.
MartinDDOVilasGLPrescherJARajaiahGFalckJRBertozziCRBerthiaumeLG. Rapid detection, discovery, and identification of post- translationally myristoylated proteins during apoptosis using a bio-orthogonal azidomyristate analog. FASEB J2008; 22: 797–806.
51.
MahalLKYaremaKJBertozziCR. Engineering chemical reactivity on cell surfaces through -oligosaccharide biosynthesis. Science1997; 276: 1125–8.
52.
IwasakiYMatsunagaAFujiiS. Preparation of biointeractive glycoprotein-conjugated hydrogels through metabolic oligosacchalide engineering. Bioconjugate Chem2014; 25: 1626–31.
53.
PattersonDMNazarovaLAPrescherJA. Finding the right (bioorthogonal) chemistry. ACS Chem Biol2014; 9: 592–605.
54.
PrescherJABertozziCR. Chemistry in living systems. Nat Chem Biol2005; 1: 13–21.
55.
DanonDGoldsteinLMarikovskyYSkutelskyE. Use of cationized ferritin as a label of negative charges on cell surfaces. J Ultra Mol Struct Res1972; 38: 500–10.
56.
LawrenceMSPhillipsKJLiuDR. Supercharging proteins can impart unusual resilience. J Am Chem Soc2007; 129: 10110–2.
57.
McNaughtonBRCronicanJJThompsonDBLiuDR. Mammalian cell penetration, siRNA transfection, and DNA transfection by supercharged proteins. Proc Natl Acad Sci U S A2009; 106: 6111–6.
58.
CronicanJJThompsonDBBeierKTMcNaughtonBRCepkoCLLiuDR. Potent delivery of functional proteins into mammalian cells. ACS Chem Biol2010; 5: 747–52.
59.
ThompsonDBVillaseñorRDorrBMZerialMLiuDR. Cellular uptake mechanisms and endosomal trafficking of supercharged proteins. Chem Biol2012; 19: 831–43.
60.
KimSAPeacockJS. The use of palmitate-conjugated protein A for coating cells with artificial receptors which facilitate intercellular interactions. J Immunol Methods1993; 158: 57–65.
61.
DennisJECohenNGoldbergVMCaplanAI. Targeted delivery of progenitor cells for cartilage repair. J Orthop Res2004; 22: 735–41.
KeanTJDueslerLYoungRGDadabayevAOlenyikAPennMWagnerJFinkDJCaplanAIDennisJE. Development of a peptide-targeted, myocardial ischemia-homing, mesenchymal stem cell. J Drug Target2012; 20: 23–32.
64.
ChenAZhengGTykocinskiML. Hierarchical costimulator thresholds for distinct immune responses: application of a novel two-step Fc fusion protein transfer method. J Immunol2000; 164: 705–11.
65.
LoCYAntonopoulosADellAHaslamSMLeeTNeelameghamS. The use of surface immobilization of P-selectin glycoprotein ligand-1 on mesenchymal stem cells to facilitate selectin mediated cell tethering and rolling. Biomaterials2013; 34: 8213–22.
66.
ZhengGChenASternerREZhangPJPanTKiyatkinNTykocinskiML. Induction of antitumor immunity via intratumoral tetra-costimulator protein transfer. Cancer Res2001; 61: 8127–34.
67.
ZhengGLiuSWangPXuYChenA. Arming tumor-reactive T cells with costimulator B7-1 enhances therapeutic efficacy of the T cells. Cancer Res2006; 66: 6793–9.
68.
LiuSBreiterDRZhengGChenA. Enhanced antitumor responses elicited by combinatorial protein transfer of chemotactic and costimulatory molecules. J Immunol2007; 178: 3301–6.
69.
LiuSFosterBAChenTZhengGChenA. Modifying dendritic cells via protein transfer for antitumor therapeutics. Clin Cancer Res2007; 13: 283–91.
70.
McHughRSAhmedSNWangY-CSellKWSelvarajP. Construction, purification, and functional incorporation on tumor cells of glycolipid-anchored human B7-1 (CD80). Proc Natl Acad Sci U S A1995; 92: 8059–63.
BrunschwigEBFayenJDMedofMETykocinskiML. Protein transfer of glycosyl-phosphatidylinositol (GPI)-modified murine B7-1 and B7-2 costimulators. J Immunother1999; 22: 390–400.
73.
McHughRSNagarajanSWangY-CSellKWSelvarajP. Protein transfer of glycosyl-phosphatidylinositol-B7-1 into tumor cell membranes: a novel approach to tumor immunotherapy. Cancer1999; 59: 2433–7.
74.
PolosoNNagarajanSBumgarnerGWZampellJCSelvarajP. Designer cancer vaccines made easy: protein transfer of immunostimulatory molecules for use in therapeutic tumor vaccines. J Immunol2001; 6: 760–75.
75.
PolosoNJNagarajanSBumgarnerGWSelvarajP. Development of therapeutic vaccines by direct modification of cell membranes from surgically removed human tumor tissue with immunostimulatory molecules. Vaccine2001; 19: 2029–38.
76.
GehoDHFayenJDJackmanRMBranchDMoodyDBPorcelliSATykocinskiML. Glycosyl-phosphatidylinositol reanchoring unmasks distinct antigen-presenting pathways for CD1b and CD1c. J Immunol2000; 165: 1272–7.
77.
NagarajanSSelvarajP. Glycolipid-anchored IL-12 expressed on tumor cell surface induces antitumor immune response. Cancer Res2002; 62: 2869–74.
LinAYDevauxBGreenASagerströmCElliottJFDavisMM. Expression of T cell antigen receptor heterodimers in a lipid-linked form. Science1987; 249: 23–5.
80.
NotohamiprodjoMDjafarzadehRMojaatAvon LüttichauIGröneH-JNelsonPJ. Generation of GPI-linked CCL5 based chemokine receptor antagonists for the suppression of acute vascular damage during allograft transplantation. Protein Eng Des Sel2006; 19: 27–35.
81.
KnorrBRDustinML. The lymphocyte function – associated antigen 1 I domain is a transient binding module for intercellular adhesion molecule (ICAM)-1 and ICAM-3 in hydrodynamic flow. J Exp Med1997; 186: 719–30.
82.
CoeshottCGreyHM. Transfer of antigen-presenting capacity to Ia-negative cells upon fusion with Ia-bearing liposomes. J Immunol1985; 134: 1343–8.
83.
PetersonBR. Synthetic mimics of mammalian cell surface receptors: prosthetic molecules that augment living cells. Org Biomol Chem2005; 3: 3607–12.
84.
LeglerDFDouceyM-ASchneiderPChapatteLBenderFCBronC. Differential insertion of GPI-anchored GFPs into lipid rafts of live cells. FASEB J2004; 19: 73–5.
85.
SarkarDVemulaPKWeianZGuptaAKarnikRKarpJM. Engineered mesenchymal stem cells with self-assembled vesicles for systemic cell targeting. Biomaterials2010; 31: 5266–74.
RabukaDForstnerMBGrovesJTBertozziCR. Noncovalent cell surface engineering: incorporation of bioactive synthetic glycopolymers into cellular membranes. J Am Chem Soc2008; 130: 5947–53.
88.
Van BroekhovenCLParishCRVassiliouGAltinJG. Engrafting costimulator molecules onto tumor cell surfaces with chelator lipids: a potentially convenient approach in cancer vaccine development. J Immunol2015; 164: 2433–43.
89.
BreydoLSunYMakaravaNLeeC-INovitskaiaVBocharovaOKaoJPYBaskakovIV. Nonpolar substitution at the C-terminus of the prion protein, a mimic of the glycosylphosphatidylinositol anchor, partially impairs amyloid fibril formation. Biochemistry2007; 46: 852–61.
90.
AbeHGotoMKamiyaN. Protein lipidation catalyzed by microbial transglutaminase. Chem Eur J2011; 17: 14004–8.
91.
ChouSHShettyAVGengYXuLMunirathinamGPipathsoukATanIMorrisTWangBChenAZhengG. Palmitate-derivatized human IL-2: a potential anticancer immunotherapeutic of low systemic toxicity. Cancer Immunol Immunother2013; 62: 597–603.
92.
ShiGMukthavaramRKesariSSimbergD. Distearoyl anchor-painted erythrocytes with prolonged ligand retention and circulation properties in vivo. Adv Healthc Mater2014; 3: 142–8.
93.
HeXBonaparteNKimSAcharyaBLeeJ-YChiLLeeH-JPaikY-KMoonP-GBaekM-CLeeE-KKimJ-HKimI-SLeeB-H. Enhanced delivery of T cells to tumor after chemotherapy using membrane-anchored, apoptosis-targeted peptide. J Control Release2012; 162: 521–8.
94.
TomitaUYamaguchiSSugimotoYTakamoriSNagamuneT. Poly(ethylene glycol)-lipid-conjugated antibodies enhance dendritic cell phagocytosis of apoptotic cancer cells. Pharmaceuticals2012; 5: 405–16.
95.
TomitaUYamaguchiSMaedaYChujoKMinamihataKNagamuneT. Protein cell-surface display through in situ enzymatic modification of proteins with a poly(ethylene glycol)-lipid. Biotechnol Bioeng2013; 110: 2785–9.
96.
AntosJMMillerGMGrotenbregGMPloeghHL. Lipid modification of proteins through sortase-catalyzed transpeptidation. J Am Chem Soc2008; 130: 16338–43.
97.
GallatF-XBroganAPSFichouYMcGrathNMoulinMHärtleinMCombetJWuttkeJMannSZaccaiGJacksonCJPerrimanAWWeikM. A polymer surfactant corona dynamically replaces water in solvent-free protein liquids and ensures macromolecular flexibility and activity. J Am Chem Soc2012; 134: 13168–71.
98.
BroganAPSSessionsRBPerrimanAWMannS. Molecular dynamics simulations reveal a dielectric-responsive coronal structure in protein – polymer surfactant hybrid nanoconstructs. J Am Chem Soc2014; 136: 16824–31.
StephanopoulosNFrancisMB. Choosing an effective protein bioconjugation strategy. Nat Chem Biol2011; 7: 876–84.
101.
SarkarDVemulaPKTeoGSLSpelkeDKarnikRWeeLYKarpJM. Chemical engineering of mesenchymal stem cells to induce a cell rolling response. Bioconjugate Chem2008; 19: 2105–9.
SwistonAJChengCUmSHIrvineDJCohenRERubnerMF. Surface functionalization of living cells with multilayer patches. Nano Lett2008; 8: 4446–53.
105.
PolakRCrouzierTLimRMRibbeckKBeppuMMPitomboRNMCohenRERubnerMF. Sugar-mediated disassembly of mucin/lectin multi layers and their use as pH-tolerant, on- demand sacrificial layers. Biomacromolecules2014; 15: 3093–8.
106.
SwistonAJGilbertJBIrvineDJCohenRERubnerMF. Freely suspended cellular “backpacks” lead to cell aggregate self-assembly. Biomacromolecules2010; 11: 1826–32.
107.
DoshiNSwistonAJGilbertJBAlcarazMLCohenRERubnerMFMitragotriS. Cell-based drug delivery devices using phagocytosis-resistant backpacks. Adv Mater2011; 23: H105–9.
108.
AnselmoACGilbertJBKumarSGuptaVCohenRERubnerMFMitragotriS. Monocyte-mediated delivery of polymeric backpacks to inflamed tissues: a generalized strategy to deliver drugs to treat inflammation. J Control Release2015; 199: 29–36.
109.
XiaJWangZHuangDYanYLiYGuanJ. Asymmetric biodegradable microdevices for cell-borne drug delivery. ACS Appl Mater Interfaces2015; 7: 6293–9.
110.
WangZXiaJYanYTsaiA-CLiYMaTGuanJ. Facile functionalization and assembly of live cells with microcontact-printed polymeric biomaterials. Acta Biomater2015; 11: 80–7.
111.
PinatoGRaffaelliTD’EsteETavanoFCojocD. Optical delivery of liposome encapsulated chemical stimuli to neuronal cells. J Biomed Opt2011; 16: 095001–095001.
112.
D’EsteEBajGBeuzerPFerrariEPinatoGTongiorgiECojocD. Use of optical tweezers technology for long-term, focal stimulation of specific subcellular neuronal compartments. Integr Biol2011; 3: 568–77.
